{
    "Clinical Trial ID": "NCT02279108",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Double Detection Indocyanine + Isotope",
        "  intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery",
        "  indocyanine green: One injection, 2.5 milligrams per patient, intradermal use",
        "  isotope: One injection, 20 MBq techntium99, intradermal use",
        "INTERVENTION 2: ",
        "  Isotope Detection Alone",
        "  intradermal injection of 20 MBq of technetium 99 before breast surgery",
        "  isotope: One injection, 20 MBq techntium99, intradermal use"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Histologically proved infiltrating breast cancer (ductal, lobular carcinoma\u2026) or a carcinoma in-situ with an elevated risk of micro-invasion. (High grade with necrosis, radiologically evaluated size more than 40mm, or immediate mastectomy\u2026)",
        "  Unifocal or multifocal but in same quarter",
        "  Size < 5cm clinically palpable or not",
        "  Clinically or ultrasound axillary N0",
        "  Isotopic sentinel node detection",
        "  Adult patient",
        "  Signed informed consent by patient or legally responsable authority",
        "  Patient registered to a social security system",
        "  No surgical contra-indication",
        "Exclusion Criteria:",
        "  Mammary carcinoma recurrence",
        "  Previous same side mammary reduction",
        "  Previous lumpectomy",
        "  Contra-indication to surgery",
        "  Pregnant or breast feeding patient",
        "  Denial of participation"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Number of Patients With Less Than Two Lymph Nodes Detected",
        "  Number of patients with less than two lymph nodes detected by indocyanine (ICG) + isotope versus isotope detection alone",
        "  Time frame: peroperative",
        "Results 1: ",
        "  Arm/Group Title: Double Detection Indocyanine + Isotope",
        "  Arm/Group Description: intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery",
        "  indocyanine green: One injection, 2.5 milligrams per patient, intradermal use",
        "  isotope: One injection, 20 MBq techntium99, intradermal use",
        "  Overall Number of Participants Analyzed: 50",
        "  Measure Type: Count of Participants",
        "  Unit of Measure: Participants  22  44.0%",
        "Results 2: ",
        "  Arm/Group Title: Isotope Detection Alone",
        "  Arm/Group Description: intradermal injection of 20 MBq of technetium 99 before breast surgery",
        "  isotope: One injection, 20 MBq techntium99, intradermal use",
        "  Overall Number of Participants Analyzed: 49",
        "  Measure Type: Count of Participants",
        "  Unit of Measure: Participants  20  40.8%"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/50 (0.00%)",
        "Adverse Events 2:",
        "  Total: "
    ]
}